MARIA MERCEDES
GIL CAMPOS

Foto de MARIA MERCEDES

Foto de Mónica

Mónica
Olivares Martín

Mónica Olivares Martín-rekin lankidetzan egindako argitalpenak (6)

2022

Docosahexaenoic and Eicosapentaenoic Intervention Modifies Plasma and Erythrocyte Omega-3 Fatty Acid Profiles But Not the Clinical Course of Children With Autism Spectrum Disorder: A Randomized Control Trial
Frontiers in Nutrition, Vol. 9

2020

Effects of Lactobacillus fermentum CECT5716 Lc40 on infant growth and health: a randomised clinical trial in nursing women
Beneficial microbes, Vol. 11, Núm. 3, pp. 235-244

2019

Evaluation of the safety, tolerance and efficacy of 1-year consumption of infant formula supplemented with Lactobacillus fermentum CECT5716 Lc40 or Bifidobacterium breve CECT7263: A randomized controlled trial
BMC Pediatrics, Vol. 19, Núm. 1

2015

Long-term safety of early consumption of Lactobacillus fermentum CECT5716: A 3-year follow-up of a randomized controlled trial
Pharmacological Research, Vol. 95-96, pp. 12-19

2012

Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1-6 months of age: A Randomized Controlled Trial
Pharmacological Research, Vol. 65, Núm. 2, pp. 231-238
Szczep Lactobacillus fermentum CECT5716 jest bezpieczny i dobrze tolerowany u niemowla̧t w wieku 1-6 miesiȩcy: randomizowane badanie kliniczne z grupa̧ kontrolna̧
Pediatria Polska, Vol. 87, Núm. 6, pp. 656-666